IP Library Assignment 018190/0279
Patent Assignment
Reel/Frame 018190/0279

Assignment of Assignor's Interest

Recorded: 2006-08-28 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2006-08-16
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Rnai Modulation of Hif-1 and Therapeutic Uses Thereof
Patent: 7,737,265 →
Application: 11/477,028 →
Publication: US 2007/0155686
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 28, 2006
From: VORNLOCHER, HANS-PETER; HADWIGER, PHILIPP
To: ALNYLAM EUROPE AG
Reel/Frame 018190/0353 →
Assignment of Assignor's Interest Sep 21, 2006
From: AKINC, AKIN; FOUGEROLLES, ANTONIN DE
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 018294/0493 →
Assignment of Assignor's Interest Feb 20, 2007
From: BRAMLAGE, BIRGIT
To: ALNYLAM EUROPE AG
Reel/Frame 018914/0927 →
Assignment of Assignor's Interest Feb 20, 2007
From: ALNYLAM EUROPE AG
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 018914/0930 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →